KR20190082524A - Method for preparation of isoquercetin and α-glycosylisoquercetin - Google Patents
Method for preparation of isoquercetin and α-glycosylisoquercetin Download PDFInfo
- Publication number
- KR20190082524A KR20190082524A KR1020180000228A KR20180000228A KR20190082524A KR 20190082524 A KR20190082524 A KR 20190082524A KR 1020180000228 A KR1020180000228 A KR 1020180000228A KR 20180000228 A KR20180000228 A KR 20180000228A KR 20190082524 A KR20190082524 A KR 20190082524A
- Authority
- KR
- South Korea
- Prior art keywords
- isoquercetin
- enzyme
- water
- hours
- glycosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 title claims abstract description 137
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 title claims abstract description 137
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 title claims abstract description 134
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 title claims abstract description 100
- 238000000034 method Methods 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 15
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 15
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 15
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 12
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 12
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000005493 rutin Nutrition 0.000 claims abstract description 12
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 12
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract description 12
- 229960004555 rutoside Drugs 0.000 claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims description 67
- 108090000790 Enzymes Proteins 0.000 claims description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000002244 precipitate Substances 0.000 claims description 29
- 238000004519 manufacturing process Methods 0.000 claims description 23
- 239000003002 pH adjusting agent Substances 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 108090000992 Transferases Proteins 0.000 claims description 4
- 102000004357 Transferases Human genes 0.000 claims description 4
- 238000000909 electrodialysis Methods 0.000 claims description 4
- 238000002523 gelfiltration Methods 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 4
- 238000005342 ion exchange Methods 0.000 claims description 4
- 230000005923 long-lasting effect Effects 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000003014 ion exchange membrane Substances 0.000 claims description 3
- 238000001223 reverse osmosis Methods 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 108700023372 Glycosyltransferases Proteins 0.000 claims description 2
- 102000051366 Glycosyltransferases Human genes 0.000 claims description 2
- 230000003413 degradative effect Effects 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 239000003381 stabilizer Substances 0.000 abstract description 4
- 239000006097 ultraviolet radiation absorber Substances 0.000 abstract description 3
- 210000000577 adipose tissue Anatomy 0.000 abstract description 2
- 239000003638 chemical reducing agent Substances 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 59
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 108010001078 naringinase Proteins 0.000 description 11
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 10
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 10
- 229930019673 naringin Natural products 0.000 description 10
- 229940052490 naringin Drugs 0.000 description 10
- 239000007787 solid Substances 0.000 description 8
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229930182470 glycoside Natural products 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- -1 flavonoid compounds Chemical class 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 108010030923 hesperidinase Proteins 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000292702 Rheum nobile Species 0.000 description 1
- 235000006385 Rheum nobile Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 108010044879 alpha-L-rhamnosidase Proteins 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01019—Cyclomaltodextrin glucanotransferase (2.4.1.19)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
본 발명은 이소케르세틴 및 α-글리코실이소케르세틴의 제조방법에 관한 것으로서, 구체적으로는 산화방지제, 색소 안정화제, 향기변화 방지제, 자외선 흡수제, 체지방 감소제 등으로서 식품, 화장품 분야에 널리 사용할 수 있는 α-글리코실이소케르세틴과 그 중간체인 이소케르세틴을 높은 수율과 순도로 제조하는 방법에 관한 것이다.The present invention relates to a method for producing isoquercetin and? -Glycosyl isoquercetin, and specifically relates to a method for producing isoquercetin and? -Glycosyl isoquercetin which can be widely used in food and cosmetic fields as antioxidants, colorant stabilizers, The present invention relates to a process for producing? -glycosyl isoquercetin and its intermediate isoquercetin with high yield and purity.
식물유래의 플라보노이드(Flavonoid)는 노란색 계통의 색소로 페닐기 2개가 C3 사슬에 매개하여 C6-C3-C6형 탄소 골격구조로 되어 있으며, 이것이 여러 당류와 배당체(glycoside)로 결합하여 존재한다.Plant-derived flavonoids are yellow-based pigments. Two phenyl groups mediate the C3 chain to form a C6-C3-C6 carbon skeleton, which is linked to glycosides by several saccharides.
케르세틴(Quercetin)은 플라보노이드계 화합물들처럼 열에 대한 불안정성, 산화 조건에 대한 불안정성 및 물에 대한 낮은 용해도 등의 한계점이 있으나, 케르세틴의 배당체는 이러한 문제점을 감소시키고 생물학적 이용율이 증가하는 것으로 알려져 있다. 케르세틴-3-글리코시드(Quercetin-3-glucoside, isoquercetin)는 케르세틴보다 일반적으로 생물학적 이용율이 3배이상 증가하는 것으로 알려져 있다(Hollman P.C. et al., in man Free Radic Res., 31(6):569, 1999; Margreet R. Olthof et al., J. Nutr., 130:12001203, 2000).Quercetin, like flavonoid compounds, has limitations such as heat instability, instability to oxidation conditions, and low solubility in water, but quercetin glycosides are known to reduce this problem and increase bioavailability. Quercetin-3-glucoside (isoquercetin) is generally known to have a 3-fold increase in bioavailability over quercetin (Hollman PC et al., In man Free Radic Res., 31 (6): 569, 1999; Margreet R. Olthof et al., J. Nutr., 130: 12001203, 2000).
또한 루틴(rutin), 이소케르세틴(isoquercetin), 헤스페레딘(hesperidine), 나린진(naringin), 네오헤스페레딘(neohesperedine) 과 같은 플라보노이드에 당을 부가하여 흡수성을 높이는 방법이 제안 (한국등록특허 10-1086441, 일본 특허공개공보 제2000-78956호 참조)되고 있으며, 회화나무 꽃 및 메밀의 주요 성분인 루틴(rutin)에 당을 전이시킨 α-글리코실루틴(α-glycosyl rutin)이 루틴보다 그 흡수성이 향상하는 것이 보고 되었다(일본 특허공개공보 2004-59522, Shimoi K. et al., J Agric Food Chem., 51, 2785-2789, 2003).There is also proposed a method of adding a sugar to a flavonoid such as rutin, isoquercetin, hesperidine, naringin and neohesperedine to increase the absorbency (Korean Patent No. 10 -1086441 and Japanese Patent Application Laid-Open No. 2000-78956), and α-glycosyl rutin, in which sugar is transferred to rutin, a main component of flower tree and buckwheat, (Japanese Patent Application Laid-Open No. 2004-59522, Shimoi K. et al., J Agric Food Chem., 51, 2785-2789, 2003).
α-글리코실이소케르세틴이 고지방식이에 의해 비만이 유도된 마우스의 체중 감소에 미치는 연구에서 마우스의 체중, 내장 지방량, 그리고 혈중지표인 중성 지방, 총 콜레스테롤 및 유리지방산의 농도를 유의적으로 감소시켰다는 보고도 있다(Yeojin Min, et al., J Korean Soc Food Sci Nutr., 45(4), 474∼483(2016).α-glycosyl isoquercetin significantly reduced the body weight, visceral fat mass, and serum triglyceride, total cholesterol, and free fatty acid concentrations of mice in a study of weight loss in obese-induced mice by high-fat diet (Yeojin Min, et al., J Korean Soc Food Sci Nutr., 45 (4), 474-483 (2016).
한편, 이소케르세틴(isoquercetin)은 케르세틴이나 루틴보다 생체 흡수성이 우수하지만 물에 난용성이므로 식품 등의 액상제품에 사용하는데 어려움이 있다. 이러한 문제점을 해소하기 위하여 당전이 효소(cyclodextrin glucano transferase)(E.C.2.4.1.19)를 사용하여 기질의 당 공여체로부터 글루코스 잔기를 당 수용체인 이소케르세틴의 글루코스 잔기 부위에 전이시킨 것이 α-글리코실이소케르세틴(α-glycosyl isoquercetin)이다. 대한민국등록특허 제1086441호 “α-글리코실이소퀘르시트린, 그의 제조 중간체, 및 부 생성물의 조제 방법”에는 ‘루틴(rutin)에서 효소적 방법으로 순도 높은 이소케르세틴을 만든 다음, 당전이효소를 이용하여 α-글리코실이소케르세틴을 제조하는 방법’이 개시되어 있다. 이때, 루틴으로부터 이소케르세틴을 생성하는 공정에 있어서, 나린긴 분해 활성을 가지는 효소로 처리하는 공정을 젤라틴, 밀 글루텐 등의 가식성 성분의 존재 하에서 수행하는 것을 특징으로 한다. 그러나 루틴으로부터 이소케르세틴을 제조할 때 수율을 높이고 추가적인 공정 없이 고순도의 이소케르세틴을 경제적으로 제조하고자 하는 과제는 여전히 남아 있다.On the other hand, isoquercetin is superior to quercetin or rutin in terms of bioabsorbability, but it is difficult to use in liquid products such as food because it is water-insoluble. In order to solve this problem, it has been proposed that a glucose residue from a sugar donor of a substrate is transferred to a glucose residue site of a sugar receptor isoquercetin using cyclodextrin glucano transferase (EC 2.4.1.19) (α-glycosyl isoquercetin). Korean Patent No. 1086441 entitled "Method for preparing α-glycosyl isoquercitrin, its preparation intermediate, and by-product", comprises preparing an isoquercetin having high purity by rutin enzymatic method and then using a glycosyltransferase A method for producing? -Glycosyl isoquercetin is disclosed. At this time, in the step of producing isoquercetin from a routine, the step of treating with an enzyme having a long-lasting cleavage activity is performed in the presence of an edible ingredient such as gelatin or wheat gluten. However, there remains a challenge to economically produce high purity isoquercetin without increasing the yield and further processing when producing isoquercetin from a routine.
본 발명자들은 α-글리코실이소케르세틴과 그 중간체인 이소케르세틴의 제조방법에 관하여 연구하였으며, 루틴으로부터 이소케르세틴을 효소적인 방법에 의하여 제조할 때, 생성되는 람노오스를 반응계로부터 제거하면서 반응을 진행시키는 경우 높은 수율로 고순도의 이소케르세틴을 제조할 수 있음을 확인하여 본 발명을 완성하였다.The inventors of the present invention have studied about a method for producing? -Glycosyl isoquercetin and its intermediate isoquercetin, and when preparing isoquercetin from an enzyme by an enzymatic method, the produced rhamnose is removed from the reaction system and the reaction is proceeded It was confirmed that high purity isoquercetin can be produced at a high yield and the present invention has been completed.
본 발명은 루틴으로부터 높은 수율로 고순도의 이소케르세틴을 제조하는 방법을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a method for producing high purity isoquercetin from a routine with high yield.
또한, 본 발명은 상기 고순도의 이소케르세틴을 이용하여 α-글리코실이소케르세틴을 제조하는 방법을 제공하는 것을 다른 목적으로 한다.Another object of the present invention is to provide a method for producing? -Glycosyl isoquercetin using the high purity isoquercetin.
상기 목적을 달성하기 위하여 본 발명에 따르면, (A)루틴을 나린긴 분해 활성을 갖는 효소로 처리하여 반응시키는 단계; (B)생성된 람노오스를 반응계에서 제거하면서 효소 반응시키는 단계; 및 (C)효소를 실활시킨 후 이소케르세틴을 수득하는 단계를 포함하는 이소케르세틴의 제조방법이 제공된다.According to the present invention, there is provided a process for preparing a compound of formula (I), which comprises: (A) treating a rutin with an enzyme having a long cleavage activity; (B) reacting the produced rhamnose with an enzyme while removing it from the reaction system; And (C) inactivating the enzyme to obtain isoquercetin.
상기 루틴은 95~98%의 순도를 가지는 것이며, 바람직하게는 95%의 순도를 가지는 것이다.The routine has a purity of 95 to 98%, preferably 95%.
상기 나린긴 분해 활성을 갖는 효소는 나린기나제, α-1,6-람노시다제, 헤스페리디나제 또는 펙티나제이며, 바람직하게는 나린기나제이다.The enzyme having the above-mentioned long-decomposing activity is a naringinase,? -1,6-rhamoxidase, hesperidinase, or pectinase, preferably a naringinase or an agonist.
상기 (A), (B)단계에서 효소반응 조건은 pH 3.5∼8, 바람직하게는 3.5∼6, 반응온도 30℃∼80℃, 바람직하게는 40℃∼80℃이다.In the above steps (A) and (B), the enzyme reaction conditions are pH 3.5 to 8, preferably 3.5 to 6,
상기 (B)단계에서 람노오스를 반응계에서 제거하는 방법으로는 원심분리법; 흡착법, 이온교환처리법, 겔 여과법과 같은 수지처리법; 한외막처리법, 역삼투막처리법, 이온교환막처리법과 같은 막처리법; 전기투석법; 용매재결정법; 및 활성탄처리법으로 이루어지는 군으로부터 선택되는 적어도 하나의 방법이 사용될 수 있으며, 바람직하게는 원심분리법이 사용된다.The method for removing rhamnose from the reaction system in the step (B) includes centrifugation; A resin treatment method such as an adsorption method, an ion exchange treatment method, and a gel filtration method; A membrane treatment method such as an ultrafiltration membrane treatment, a reverse osmosis membrane treatment method, and an ion exchange membrane treatment method; Electrodialysis; Solvent recrystallization; And activated carbon treatment may be used. Preferably, centrifugation is used.
바람직하게는 (A) a1)순도 95~98%의 루틴을 물에 분산시키고 pH 조정제를 사용하여 Ph3.5~8로 조정하는 단계; a2)나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계;(A) a1) dispersing the rutin having a purity of 95 to 98% in water and adjusting pH to 3.5 to 8 using a pH adjusting agent; a2) adding an enzyme having a long-lasting cleavage activity and reacting at 30 to 80 DEG C with stirring;
(B) b1)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리 후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b2)침전물을 물에 분산시키고 pH 조정제를 사용하여 pH3.5~8로 조정하고, 나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계; b3)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b4)침전물을 다시 물에 분산시키고 효소 추가 투여 없이 30~80℃에서 교반하면서 20~24시간 반응시키는 단계; 및(B) b1) After 20 to 24 hours of keeping, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b2) dispersing the precipitate in water, adjusting the pH to 3.5 to 8 using a pH adjuster, adding an enzyme having a naringly digesting activity and reacting at 30 to 80 캜 with stirring; b3) After maintaining the temperature for 20 to 24 hours, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b4) dispersing the precipitate in water again and reacting at 30 to 80 DEG C for 20 to 24 hours with no additional enzyme added; And
(C)반응계에 남아있는 효소를 실활시킨 후 침전물을 물로 세척, 건조하여 이소케르세틴을 회수하는 단계를 포함하는 이소케르세틴의 제조방법이 제공된다.(C) deactivating the enzyme remaining in the reaction system, washing the precipitate with water, and drying the recovered isoquercetin, thereby recovering the isoquercetin.
상기 다른 목적을 달성하기 위하여 본 발명에 따르면, 상기 제조방법에 의하여 제조된 이소케르세틴을 당공여체의 존재하에 당전이 효소 처리하는 단계를 포함하는 하기 화학식으로 표시되는 α-글리코실이소케르세틴의 제조방법이 제공된다.According to another aspect of the present invention, there is provided a method for producing? -Glycosyl isoquercetin represented by the following formula, which comprises subjecting isoquercetin prepared by the above production method to glycosylation in the presence of a sugar donor / RTI >
(n은0~12의 정수) (n is an integer of 0 to 12)
상기 당공여체는 덱스트린, 사이클로덱스트린 또는 전분이다. 상기 당전이 효소는 사이클로덱스트린 글루카노 트랜스퍼라아제(cyclodextrin glucanotransferase)이다.The sugar donor is dextrin, cyclodextrin or starch. The glycoprotein is cyclodextrin glucanotransferase.
바람직하게는 (A)상기에서 얻어진 이소케르세틴에 물을 가하고 pH 조정제로 pH 5~8.5로 조정 후 30~80℃로 1~2 시간 유지시키는 단계;Preferably, (A) adding water to the isoquercetin obtained above, adjusting the pH to 5 to 8.5 with a pH adjusting agent, and maintaining the temperature at 30 to 80 ° C for 1 to 2 hours;
(B)당공여체를 첨가하여 분산시키고, 당전이효소를 첨가하여 pH 5~8.5, 30~80℃조건에서 20~24시간 반응시키는 단계; 및(B) a donor is added and dispersed, and a reaction is carried out at
(C)효소를 실활시킨 후, 여과, 농축, 건조시켜 α-글리코실이소케르세틴을 회수하는 단계를 포함하는 α-글리코실이소케르세틴의 제조방법이 제공된다.(C) deactivating the enzyme, followed by filtration, concentration, and drying to recover the? -Glycosyl isoquercetin, there is provided a process for producing? -Glycosyl isoquercetin.
본 발명의 제조방법에 따르면, 루틴으로부터 효소적 방법에 의하여 이소케르세틴을 제조함에 있어서, 반응계에서 유리 람노오스를 제거하면서 효소 반응시키는 간단한 공정에 의하여 높은 수율로 고순도의 이소케르세틴을 제조할 수 있으므로 매우 경제적으로 α-글리코실이소케르세틴을 제조할 수 있는 장점이 있다.According to the production method of the present invention, in the production of isoquercetin from an enzyme by an enzymatic method, high-purity isoquercetin can be produced at a high yield by a simple process of enzymatic reaction while removing free rhamnose from the reaction system. There is an advantage that? -Glycosyl isoquercetin can be produced economically.
도 1은 본 발명의 일 실시예에 따라 제조된 α-글리코실이소케르세틴의 배당체 조성물 비율을 나타내는 분석도이다.BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is an analysis chart showing the glycoside composition ratios of? -Glycosyl isoquercetin prepared according to an embodiment of the present invention.
본 발명은 산화방지제, 색소 안정화제, 향기변화 방지제, 자외선 흡수제, 체지방 감소제 등으로서 식품, 화장품 분야에 널리 사용할 수 있는 α-글리코실이소케르세틴과 그 중간체인 이소케르세틴의 제조공정을 단순화하여 경제적으로 우수한 제조방법을 제공하는 것을 기술적 특징으로 한다.The present invention simplifies the production process of? -Glycosyl isoquercetin and its intermediate isoquercetin, which can be widely used in foods and cosmetics fields as an antioxidant, a pigment stabilizer, an anti-aroma agent, an ultraviolet absorber, To provide an excellent manufacturing method.
하기 화학식으로 표시되는 이소케르세틴(isoquercetin, Quercetin-3-glucoside)은 케르세틴의 3-O-글루코시드이다. 망고(Mangifera indica), 대황(Rheum nobile), 회화나무(sophora japonica) 등의 다양한 식물 종에서 분리할 수 있다.Isoquercetin (Quercetin-3-glucoside) represented by the following formula is 3-O-glucoside of quercetin. Can be isolated from a variety of plant species such as mangifera indica, rheum nobile, and sophora japonica.
이소케르세틴은 우수한 항산화제로서 미백활성을 나타내며, 혈압을 낮추고 항암활성을 가지는 것으로 알려져 있다. 또한, 이소케르세틴은 산화방지제, 색소 안정화제, 향기변화 방지제, 자외선 흡수제, 체지방 감소제 등으로서 식품, 화장품 분야에 널리 사용되는 α-글리코실이소케르세틴의 제조에 있어서 중간체가 된다. 이소케르세틴을 대량으로 제조하는 방법에는 화학적인 합성법, 효소법 등이 알려져 있다.Isoquercetin is an excellent antioxidant and has a whitening activity, lowering blood pressure and having anticancer activity. In addition, isoquercetin is an intermediate in the production of? -Glycosyl isoquercetin widely used in food and cosmetic fields as an antioxidant, a pigment stabilizer, an anti-aroma agent, an ultraviolet absorber, and a body fat reducing agent. Methods for mass production of isoquercetin include chemical synthesis, enzymatic methods, and the like.
본 발명은 루틴을 출발물질로 하여 효소법에 의하여 이소케르세틴을 대량으로 생산하는 방법에 관한 것이다. 본 발명자들은 종래 루틴에 람노시다제 효소를 처리하여 이소케르세틴을 제조할 때, 낮은 수율과 순도에 한계가 있다는 것을 발견하였다. 특히 반응계에 유리된 람노오스가 누적될수록 이소케르세틴으로의 전환 반응을 억제한다는 사실을 발견하였다.The present invention relates to a method for mass production of isoquercetin by an enzymatic method using as a starting material. The present inventors have found that there is a limit to low yield and purity when preparing isoquercetin by treating a ruminosidase enzyme with conventional routines. In particular, it has been found that the accumulation of free rhamnose in the reaction system inhibits the conversion to isoquercetin.
위와 같은 문제점을 해결하기 위하여 본 발명에 따르면, (A)루틴을 나린긴 분해 활성을 갖는 효소로 처리하여 반응시키는 단계; (B)생성된 람노오스를 반응계에서 제거하면서 효소 반응시키는 단계; 및 (C)효소를 실활시킨 후 이소케르세틴을 수득하는 단계를 포함하는 이소케르세틴의 제조방법이 제공된다. According to an aspect of the present invention, there is provided a method for preparing a compound of formula (I), comprising the steps of: (A) treating a rutin with an enzyme having a long degradative activity; (B) reacting the produced rhamnose with an enzyme while removing it from the reaction system; And (C) inactivating the enzyme to obtain isoquercetin.
상기 루틴은 95~98%의 순도를 가지는 것이며, 바람직하게는 95%의 순도를 가지는 것이다. 순도가 낮은 95%의 루틴을 사용하는 경우에 이소케르세틴으로의 전환율이 오히려 높다는 것을 확인하였다.The routine has a purity of 95 to 98%, preferably 95%. It was confirmed that the conversion rate to isoquercetin was rather high when 95% of low-purity routines were used.
상기 나린긴 분해 활성을 갖는 효소로는 나린기나제, α-1,6-람노시다제(E.C.3.2.1.40), 헤스페리디나제 또는 펙티나제이며가 사용될 수 있으며, 바람직하게는 α-L-람노시다제(alpha-L-rhamnosidase)와 베타 글루코시다제(beta glucosidase) 활성을 동시에 갖는 복합 효소제 나린기나제를 사용한다.Examples of the enzymes having the above-mentioned long-decomposing activity include naringinase, α-1,6-rhamnosidase (EC 3.2.1.40), hesperidinase or pectinase, preferably α-L L-rhamnosidase and a beta-glucosidase activity are used as the enzyme.
루틴 1 중량부에 대한 나린긴 분해 효소의 사용량으로는 이를 테면, 효소 역가가 150단위/g(1단위: pH3.5에서 30분 동안 1 mg의 람노오스에 상당하는 환원당을 생성할 때의 효소량)의 분해 효소를 사용할 경우, 1~20단위(0.006∼0.13 중량부) 범위로 사용할 수가 있고, 바람직하게는 1~15 단위(0.006∼0.1 중량부) 정도, 더 바람직하게는 1~10단위(0.006∼0.06 중량부) 정도이다.The amount of naringin long-term degrading enzyme used per 1 part by weight of the routine is, for example, the amount of enzyme when the enzyme activity is 150 units / g (1 unit: pH3.5 to produce reducing sugar equivalent to 1 mg of rhamnose for 30 minutes (0.006 to 0.13 part by weight), preferably about 1 to 15 units (0.006 to 0.1 part by weight), more preferably 1 to 10 units ( 0.006 to 0.06 part by weight).
또한 루틴의 반응농도는 반응계 100% 중량% 중에 1∼20 중량%, 바람직하게는 1∼15 중량%, 더 바람직하게는 1∼10 중량% 이다.Also, the reaction concentration of the routine is 1 to 20% by weight, preferably 1 to 15% by weight, more preferably 1 to 10% by weight in 100% by weight of the reaction system.
상기 (A), (B)단계에서 효소반응 조건은 pH 3.5∼8, 더욱 바람직하게는 3.5∼6, 반응온도 30℃∼80℃, 더욱 바람직하게는 40℃∼80℃이다. 온도 및 pH 조건은 사용하는 효소의 종류에 따라 다르지만, 나린기나제 "아마노"(150U/g)(일본) 또는 이에 준하는 나린긴 분해 효소를 사용할 경우, pH는 3.5∼8이고, 바람직하게는 3.5∼6 범위이다. 반응온도 조건도 사용하는 효소에 따라 다르지만, 80℃ 이하, 바람직하게는 30℃∼80℃, 보다 바람직하게는 40℃∼80℃이다.In the above steps (A) and (B), the enzyme reaction conditions are pH 3.5 to 8, more preferably 3.5 to 6,
반응계에서 유리 람노오스를 제거시키는 방법은 특별히 제한적이고 않고 관용의 방법을 임으로 조합하여 실시할 수 있다. 구체적으로는 원심분리법, 각종 수지처리법(흡착법, 이온교환처리법, 겔 여과법 등), 막처리법(한외막처리법, 역삼투막처리법, 이온교환막처리법), 전기투석법, 용매재결정법, 활성탄처리법 등이 사용될 수 있으며, 바람직하게는 원심분리법이 사용된다.The method of removing free rhamnose from the reaction system is not particularly limited, and a common method can be used in combination. Specifically, a centrifugal separation method, various resin treatment methods (adsorption method, ion exchange treatment method, gel filtration method, etc.), membrane treatment method (ultrafiltration membrane treatment, reverse osmosis membrane treatment method, ion exchange membrane treatment method), electrodialysis method, solvent recrystallization method, Preferably, a centrifugation method is used.
본 발명의 일 구체예에 따르면, (A) a1)순도 95~98%의 루틴을 물에 분산시키고 pH 조정제를 사용하여 Ph3.5~8로 조정하는 단계; a2)나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계;According to an embodiment of the present invention, there is provided a method for preparing a pharmaceutical composition, comprising: (A) a1) dispersing a routine with a purity of 95 to 98% in water and adjusting pH to 3.5 to 8 using a pH adjusting agent; a2) adding an enzyme having a long-lasting cleavage activity and reacting at 30 to 80 DEG C with stirring;
(B) b1)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리 후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b2)침전물을 물에 분산시키고 pH 조정제를 사용하여 pH3.5~8로 조정하고, 나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계; b3)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b4)침전물을 다시 물에 분산시키고 효소 추가 투여 없이 30~80℃에서 교반하면서 20~24시간 반응시키는 단계; 및(B) b1) After 20 to 24 hours of keeping, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b2) dispersing the precipitate in water, adjusting the pH to 3.5 to 8 using a pH adjuster, adding an enzyme having a naringly digesting activity and reacting at 30 to 80 캜 with stirring; b3) After maintaining the temperature for 20 to 24 hours, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b4) dispersing the precipitate in water again and reacting at 30 to 80 DEG C for 20 to 24 hours with no additional enzyme added; And
(C)반응계에 남아있는 효소를 실활시킨 후 침전물을 물로 세척, 건조하여 이소케르세틴을 회수하는 단계를 포함하는 이소케르세틴의 제조방법이 제공된다.(C) deactivating the enzyme remaining in the reaction system, washing the precipitate with water, and drying the recovered isoquercetin, thereby recovering the isoquercetin.
상기의 이소케르세틴(IQC)의 제조방법에서 24시간 마다 반응계에 유리된 람노오스를 제거하는 경우 48시간 경과 후에는 거의 100%의 순도로 IQC를 얻을 수 있었으며, 72시간 경과 후에는 100%의 순도로 이소케르세틴을 얻을 수 있었다. 본 발명은 종래의 방법에 비하여 시간은 조금 더 소요될 수 있지만, 반응계에서 유리 람노오스를 제거하면서 반응을 지속하는 간단한 공정에 의하여 그 수율과 순도를 획기적으로 높일 수 있었다.In the above isoquercetin (IQC) production method, IQC was obtained at almost 100% purity after 48 hours when rhamnose free from the reaction system was removed every 24 hours. After 72 hours, 100% purity To obtain isoquercetin. The present invention can take a little longer time than the conventional method, but its yield and purity can be dramatically increased by a simple process in which the reaction is continued while free rhamnose is removed from the reaction system.
이소케르세틴(isoquercetin)은 케르세틴이나 루틴보다 생체 흡수성이 우수하지만 물에 난용성이므로 식품 등의 액상제품에 사용하는데 어려움이 있다. 이에 상기 본 발명의 다른 목적을 달성하기 위하여 본 발명에 따르면, 상기 제조방법에 의하여 제조된 이소케르세틴을 당공여체의 존재하에 당전이 효소 처리하는 단계를 포함하는 하기 화학식으로 표시되는 α-글리코실이소케르세틴의 제조방법이 제공된다.Isoquercetin is superior to quercetin and rutin in terms of bioabsorbability, but it is difficult to use in liquid products such as food because it is water-insoluble. According to another aspect of the present invention, there is provided a method for producing α-glycosyl iso-iso-quinazoline represented by the following formula, comprising the step of subjecting isoquercetin prepared by the above- A process for preparing quercetin is provided.
(n은0~12의 정수) (n is an integer of 0 to 12)
여기서 IQC의 배당화에 사용되는 전이효소는 사이클로덱스트린 글루카노트랜스퍼라제(cyclodextrin glucanotransferase, CGTase)(E.C.2.4.1.19) 이다. 상기 당전이 효소는 상업적으로 입수할 수 있는 효소이다. 시판되는 효소로는 상품명 Toruzyme 3.0L(3.0KNU/g, One Kilo Novo alpha-amylase Unit (1KNU):시간당 전분 5.25g을 분해할때의 효소량, Novozymes), α-Amylase G "Amano L"(400U/g, 1U:전분으로부터 β-사이클로덱스트린을 1분간 1mg 생성하는 효소량, Amano Enzyme Inc.)를 예시할 수 있다Here, the transferase used for the dividing of IQC is cyclodextrin glucanotransferase (CGTase) (E.C.2.4.1.19). The glycoprotein is a commercially available enzyme. Amylase G "Amano L" (400 U) was used as a commercially available enzyme. The amount of the enzymes was determined by the following formula: Toruzyme 3.0 L (3.0 KNU / g; One Kilo Novo alpha-amylase Unit / g, 1U: Amino Enzyme Inc.), which produces 1 mg of? -cyclodextrin from starch for 1 minute
사용되는 효소의 양은 효소에 따라 다르지만, 상품명 Toruzyme 3.0L(3.0KNU/g, One Kilo Novo alpha-amylase Unit (1KNU): 시간당 전분 5.25g을 분해할때의 효소량, Novozymes)인 경우 기질(당공여체) 1 중량부에 대하여 통상 20∼400단위(0.0066∼0.13 중량부), 바람직하게는 40∼350단위(0.013∼0.12중량부), 보다 바람직하게는 70∼250단위(0.02∼0.08 중량부) 정도이다.The amount of enzyme used varies depending on the enzyme, but in the case of Toruzyme 3.0L (3.0 KNU / g, One Kilo Novo alpha-amylase Unit (1 KNU): enzyme amount in decomposing 5.25 g starch per hour, Novozymes) (0.0066 to 0.13 parts by weight), preferably 40 to 350 parts (0.013 to 0.12 parts by weight), and more preferably 70 to 250 parts (0.02 to 0.08 parts by weight) relative to 1 part by weight to be.
배당화에 이용되는 당공여체로는 덱스트린, 사이클로덱스트린, 전분 등을 들 수 있다. 사용량은 반응계에 존재하는 IQC 1중량부에 대하여 통상 0.1∼20 중량부의 비율, 바람직하게는 0.4∼15 중량부, 보다 바람직하게는 0.4∼10 중량부 정도이다.Examples of the saccharide donor used for the saccharification include dextrin, cyclodextrin, starch, and the like. The amount to be used is usually about 0.1 to 20 parts by weight, preferably about 0.4 to 15 parts by weight, and more preferably about 0.4 to 10 parts by weight based on 1 part by weight of IQC present in the reaction system.
반응조건은 효소의 종류에 따라 다르지만, 예를 들어 85℃이하, 바람직하게는 30∼80℃, 바람직하게는 40∼75℃, pH3∼10, 바람직하게는 pH5∼8.5에서, 상기의 당공여체의 존재 하에 전이효소를 작용시킴으로써 조제할 수 있다. 상기 반응은 정치, 교반 또는 진탕하면서 행할 수 있다.The reaction conditions vary depending on the kind of the enzyme, but the reaction conditions may vary depending on the kind of the enzyme, for example, at 85 ° C or below, preferably 30-80 ° C, preferably 40-75 ° C, pH 3-10, preferably pH 5-8.5. In the presence of the enzyme. The reaction can be carried out while stirring, or shaking.
또한, α-글리코실이소케르세틴의 글루코오스 잔기의 결합수(상기 화학식의 n의 수)는 제한되지 않지만 보통은 1∼12, 바람직하게는 1∼7, 더 바람직하게는 1∼5이다. 이러한 글루코오스기의 결합수(n의 수)는 임의로 조정할 수가 있다. 특히 1∼3의 몰비율이 높아지게 할 수가 있다. 예를 들면, α-글리코실이소케르세틴의 생성 후에 각종 아밀라제(α-아밀라제, β-아밀라제, 글루코아밀라제 등)을 사용하여 1∼3의 몰비율이 높아지게 할 수가 있다. 상기 아밀라제를 처리한 반응계로부터 α-글리코실이소케르세틴을 단리, 정제할 수도 있다. α-글리코실이소케르세틴의 회수는 관용의 여러 가지 방법으로 할 수가 있으며, 예를 들어 각종 수지처리법(흡착법, 이온교환처리법, 겔 여과법 등), 막처리법(한외막처리법, 역삼투막처리법, 이온교환막처리법), 전기투석법, 용매재결정법, 활성탄처리법 등에 의해 수행할 수 있다.The number of bonds of the glucose residue of? -Glycosyl isoquercetin (the number of n in the above formula) is not limited, but is usually 1 to 12, preferably 1 to 7, more preferably 1 to 5. The number of bonds (number of n) of these glucose groups can be arbitrarily adjusted. The molar ratio of 1 to 3 can be increased. For example, after the production of? -Glycosyl isoquercetin, the molar ratio of 1 to 3 can be increased by using various amylases (? -Amylase,? -Amylase, glucoamylase, etc.). The? -Glycosyl isoquercetin may be isolated and purified from the reaction system treated with the amylase. The recovery of? -glycosyl isoquercetin can be carried out by any of a variety of conventional methods, for example, various resin treatment methods (adsorption method, ion exchange method, gel filtration method, etc.), membrane treatment method ), An electrodialysis method, a solvent recrystallization method, an activated carbon treatment method, or the like.
일 구체예에 따르면 (A)상기에서 얻어진 이소케르세틴에 물을 가하고 pH 조정제로 pH 5~8.5로 조정 후 30~80℃로 1~2 시간 유지시키는 단계;According to one embodiment, (A) adding water to the isoquercetin obtained above, adjusting the pH to 5 to 8.5 with a pH adjusting agent, and maintaining the temperature at 30 to 80 ° C for 1 to 2 hours;
(B)당공여체를 첨가하여 분산시키고, 당전이효소를 첨가하여 pH 5~8.5, 30~80℃조건에서 20~24시간 반응시키는 단계; 및(B) a donor is added and dispersed, and a reaction is carried out at
(C)효소를 실활시킨 후, 여과, 농축, 건조시켜 α-글리코실이소케르세틴을 회수하는 단계를 포함하는 α-글리코실이소케르세틴의 제조방법이 제공된다.(C) deactivating the enzyme, followed by filtration, concentration, and drying to recover the? -Glycosyl isoquercetin, there is provided a process for producing? -Glycosyl isoquercetin.
본 발명의 제조방법에 따르면, 중간체인 이소케르세틴을 간단한 공정에 의해 고수율, 고순도로 제조할 수 있으므로, 최종 산물인 α-글리코실이소케르세틴을 경제적으로 제조할 수 있다.According to the production method of the present invention, isoquercetin, which is an intermediate, can be produced with high yield and high purity by a simple process, so that the final product,? -Glycosyl isoquercetin, can be produced economically.
[실시예][Example]
이하, 하기의 실시예를 통하여 본 발명을 보다 상세히 설명한다. 그러나 이러한 실시예들은 본 발명의 기술적 사상의 내용과 범위를 쉽게 설명하기 위한 예시일 뿐, 이에 의해 본 발명의 기술적 범위가 한정되거나 변경되는 것은 아니다. 또한 이러한 예시에 기초하여 본 발명의 기술적 사상의 범위 안에서 다양한 변형과 변경이 가능함은 통상의 기술자들에게는 당연할 것이다.Hereinafter, the present invention will be described in more detail with reference to the following examples. It should be understood, however, that these embodiments are merely examples for the purpose of easily describing the scope and scope of the technical idea of the present invention, and thus the technical scope of the present invention is not limited or changed. It will be apparent to those of ordinary skill in the art that various changes and modifications can be made within the scope of the technical idea of the present invention based on these examples.
비교예 1: 이소케르세틴의 제조Comparative Example 1: Preparation of isoquercetin
순도 약 95% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 24시간 유지한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 95% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a naringin agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g), the mixture was kept at 70 캜 for 24 hours with stirring, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
비교예 2: 이소케르세틴의 제조Comparative Example 2: Preparation of isoquercetin
순도 약 95% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 48시간 유지 한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 95% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a carrier or agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g), the mixture was maintained at 70 ° C with stirring for 48 hours, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
비교예 3: 이소케르세틴의 제조Comparative Example 3: Preparation of isoquercetin
순도 약 95% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 72시간 유지 한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 95% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a naringin agent (Amano Enzyme Inc., trade name: Naringinase Amano, 150 U / g) at 70 캜 for 72 hours, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
비교예 4: 이소케르세틴의 제조Comparative Example 4: Preparation of isoquercetin
순도 약 98% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 24시간 유지 한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 98% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a naringin agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g), the mixture was kept at 70 캜 for 24 hours with stirring, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
비교예 5: 이소케르세틴의 제조Comparative Example 5: Preparation of isoquercetin
순도 약 98% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 48시간 유지 한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 98% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a carrier or agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g), the mixture was maintained at 70 ° C with stirring for 48 hours, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
비교예 6: 이소케르세틴의 제조Comparative Example 6: Preparation of isoquercetin
순도 약 98% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 72시간 유지한 후, 95℃에서 반응계에 남아 있는 효소를 실활시킨다. 얻어진 침전물(고형분)을 물로 세척, 건조하여 이소케르세틴을 회수하였다.30 g of a 98% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). After adding 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a naringin agent (Amano Enzyme Inc., trade name: Naringinase Amano, 150 U / g) at 70 캜 for 72 hours, Inactivate the remaining enzyme. The resulting precipitate (solid content) was washed with water and dried to recover isoquercetin.
시험예 1: 이소케르세틴의 순도분석Test Example 1: Purity analysis of isoquercetin
하기의 방법으로 회수된 이소케르세틴의 함량을 분석하였다.The content of recovered isoquercetin was analyzed by the following method.
이소케르세틴(IQC) 분석방법Isoquercetin (IQC) assay method
1)표준액 조제: IQC 표준품 약 20mg을 정밀히 달아 메탄올로 50mL volumetric flask로 채운 것을 표준액으로 한다.1) Preparation of standard solution: Approximately 20 mg of IQC standard product is accurately weighed and filled with methanol in a 50 mL volumetric flask.
2)검액 조제: 검체 20mg을 정밀히 달아 메탄올로 50mL volumetric flask로 채운 것을 검액으로 한다.2) Preparation of test solution: 20 mg of specimen is precisely weighed and filled with methanol in a 50 mL volumetric flask.
<HPLC 분석조건><HPLC analysis conditions>
1)칼람: C18 column (4.6 m × 250 mm, 5 μm)1) Column: C18 column (4.6 m x 250 mm, 5 m)
2)이동상: 아세토니트릴(Acetonirtile):물=18:822) mobile phase: Acetonitrile: water = 18: 82
3)검출기 및 파장: UV at 254 nm3) Detector and wavelength: UV at 254 nm
4)유속: 0.8 mL/min4) Flow rate: 0.8 mL / min
5)주입량: 10㎕5) Injection amount: 10 μl
6)칼람온도: 상온6) Column temperature: room temperature
그 결과를 하기 표 1, 2에 나타내었다.The results are shown in Tables 1 and 2 below.
(24시간)Comparative Example 1
(24 hours)
(48시간)Comparative Example 2
(48 hours)
(72시간)Comparative Example 3
(72 hours)
(24시간)Comparative Example 4
(24 hours)
(48시간)Comparative Example 5
(48 hours)
(72시간)Comparative Example 6
(72 hours)
상기 표에서 확인되는 바와 같이, 순도가 상대적으로 낮은 95% 루틴을 출발물질로 하는 경우에 IQC 전환율이 보다 높게 나타남을 알 수 있다. 다만, 시간의 경과에 따른 전환율의 상승은 크지 않음을 확인할 수 있다.As can be seen in the above table, it can be seen that the conversion of IQC is higher when the starting material is 95% of a relatively low purity. However, it can be seen that the increase in conversion rate over time is not large.
실시예 1: 이소케르세틴의 제조Example 1: Preparation of isoquercetin
순도 약 95% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 24시간 유지하였다. 25℃로 냉각하여 원심 분리 후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버린다.30 g of a 95% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a carrier or agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g) was added and kept at 70 캜 with stirring for 24 hours. After cooling to 25 ° C, the supernatant is discarded, water is added to the precipitate again, centrifuged, and the supernatant is discarded.
다시 침전물을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하고, 나린기나제 0.3g(1.5단위*30/150=0.3g)을 다시 첨가하여 70℃에서 교반하면서 추가로 24시간 유지 한 후 95℃에서 반응계에 남아 있는 효소를 실활시킨다.The precipitate was again dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjusting agent (1N NaOH, 0.01N HCl), and 0.3 g of Naringin or 0.3 g (1.5 units * 30/150 = 0.3 g) And the enzyme remaining in the reaction system is deactivated at 95 ° C for 24 hours.
얻어진 침전물(고형분)을 물로 세척 후, 건조하고, 이소케르세틴을 회수하였다.The obtained precipitate (solid content) was washed with water, and then dried to recover isoquercetin.
실시예 2: 이소케르세틴의 제조Example 2: Preparation of isoquercetin
순도 약 95% 루틴 30g을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하였다. 이에 나린기나제(Amano Enzyme Inc. 상품명 Naringinase Amano, 150U/g)를 0.6g(3단위*30g/150단위=0.6g)을 첨가하여 70℃에서 교반하면서 24시간 유지하였다. 25℃로 냉각하여 원심 분리후 상등액을 버린후, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버린다. 30 g of a 95% pure solution of purity was dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjuster (1N NaOH, 0.01 N HCl). 0.6 g (3 units * 30 g / 150 units = 0.6 g) of a carrier or agent (Amano Enzyme Inc. under the trade name of Naringinase Amano, 150 U / g) was added and kept at 70 캜 with stirring for 24 hours. After cooling to 25 ° C, centrifuge and discard the supernatant, add water again to the precipitate, centrifuge and discard the supernatant.
다시 침전물을 물 400mL에 분산시키고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH4.5로 조정하고, 나린기나제 0.3g(1.5단위*30/150=0.3g)을 다시 첨가하여 70℃에서 교반하면서 추가로 24시간 유지하고, 위와 동일하게 25℃로 냉각하여 원심 분리후 상등액을 버린후, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버린다.The precipitate was again dispersed in 400 mL of water and adjusted to pH 4.5 using a pH adjusting agent (1N NaOH, 0.01N HCl), and 0.3 g of Naringin or 0.3 g (1.5 units * 30/150 = 0.3 g) And the mixture is further stirred for 24 hours. The mixture is cooled to 25 DEG C by centrifugation, and the supernatant is discarded. Water is added to the precipitate again, centrifuged, and the supernatant is discarded.
침전물에 다시 물 400mL에 분산시키고 나린기나제 추가 투여 없이 그냥 70℃에서 교반하면서 또 24시간 유지하고 한 후 95℃에서 반응계에 남아 있는 효소를 실활시킨다.The precipitate is dispersed again in 400 mL of water, and the mixture is maintained at 70 DEG C for 24 hours without further administration of naringin or an additional agent, and the enzyme remaining in the reaction system at 95 DEG C is inactivated.
얻어진 침전물(고형분)을 물로 세척후, 건조하고, 이소케르세틴 22.5g을 회수하였다. 회수율은 99%이다.The resulting precipitate (solid content) was washed with water and then dried to recover 22.5 g of isoquercetin. The recovery rate is 99%.
시험예 2: 이소케르세틴의 순도분석Test Example 2: Purity analysis of isoquercetin
상기 시험예 1과 동일한 방법으로 회수된 이소케르세틴의 함량을 분석하였다.The content of recovered isoquercetin in the same manner as in Test Example 1 was analyzed.
그 결과를 하기 표 3에 나타내었다.The results are shown in Table 3 below.
(48시간)Example 1
(48 hours)
(72시간)Example 2
(72 hours)
상기 표 3에서 확인되는 바와 같이, 효소 반응 24시간 마다 반응계에 유리된 람노오스를 제거하면서 반응을 시킨 경우에 48시간 경과 후(실시예 1)에는 96%의 IQC 함량을 나타내었으며, 72시간 후에는 100%의 IQC 함량을 나타내었다. 유리 람노오스의 제거 없이 효소 반응시킨 상기 표 1의 비교예 2(52%), 비교예 3(53%)의 결과와 비교해 볼 때, 현저한 차이를 나타냄을 확인할 수 있었다.As shown in Table 3, when the reaction was performed while removing rhamnose free from the reaction system every 24 hours of the enzymatic reaction, the IQC content was 96% after 48 hours (Example 1), and after 72 hours Showed an IQC content of 100%. It was confirmed that the results are significantly different from those of Comparative Example 2 (52%) and Comparative Example 3 (53%) in Table 1, which were subjected to enzyme reaction without removal of free rhamnose.
실시예 3: α-글리코실이소케르세틴의 제조Example 3: Preparation of? -Glycosyl isoquercetin
상기 실시예 2에서 얻어진 이소케르세틴 20g에 물 300mL의 물을 가하고 pH 조정제(1N NaOH, 0.01N HCl)를 사용하여 pH8.5로 조정 후 75℃로 약 한 시간 정도 유지시킨다. 그리고 전분 10g을 첨가하여 분산시키고, 전이효소 Toruzyme 3.0L(3.0KNU/g, Novozymes)를 기질(당공여체) 1 중량부에 대하여 200단위(15g*200단위/3000U=1g)인 1g을 반응계에 첨가 후 pH8.0, 온도 75℃에서 24시간동안 반응시켰다. 수득된 반응액을 95℃에서 30분간 유지시켜 효소를 실활시켰다. 여과, 농축하여 분무건조시켰다. α-글리코실이소케르세틴 배당체 29g을 수득하였다.Water (300 mL) was added to 20 g of isoquercetin obtained in Example 2, adjusted to pH 8.5 with a pH adjuster (1N NaOH, 0.01 N HCl), and maintained at 75 DEG C for about one hour. Then, 10 g of starch was added and dispersed, and 1 g of a transfer unit enzyme Toruzyme 3.0 L (3.0 KNU / g, Novozymes) of 200 units (15 g * 200 unit / 3000 U = 1 g) per 1 part of the substrate (sugar donor) After the addition, the reaction was carried out at pH 8.0 and 75 ° C for 24 hours. The obtained reaction solution was kept at 95 DEG C for 30 minutes to inactivate the enzyme. Filtered, concentrated and spray dried. 29 g of? -glycosyl isoquercetin glycoside was obtained.
시험예 3: α-글리코실이소케르세틴의 함량분석Test Example 3: Content analysis of? -Glycosyl isoquercetin
이를 아래의 방법 즉, 일본 식품첨가물공전 효소처리 이소케르세틴(α-글리코실이소케르세틴) 함량 시험법으로 함량을 분석하였다.The content was analyzed by the following method, that is, the content of isoquercetin (α-glycosyl isoquercetin) in Japanese enzymes treated with food additives.
흡광도가 0.3~0.7의 범위가 되도록 수득한 α-글리코실이소케르세틴을 정밀히 달아 물 50mL를 가하여 녹인 100mL로 한 다음 다시 이 액 1mL를 정확히 취하여 0.085% 인산용액을 가하여 100mL로 한 것을 시험용액으로 하였다.The α-glycosyl isoquercetin obtained so that the absorbance is in the range of 0.3 to 0.7 is precisely weighed and dissolved in 50 ml of water to make 100 ml. 1 ml of this solution is accurately taken and 0.085% phosphoric acid solution is added to make 100 ml as the test solution .
따로, 루틴 표준품을 135℃에서 2시간 건조한 다음 약 0.2g을 정밀히 달아 메탄올 80mL를 가해주고 가열하여 녹이고 식힌 다음 메탄올을 가하여 100mL로 한 다음 다시 이 액 1mL를 취하여 0.085% 인산을 가하여 100mL로 한 것을 표준용액으로 하였다.Separately, the routine standard is dried for 2 hours at 135 ° C. Approximately 0.2 g is precisely weighed and dissolved in 80 ml of methanol, heated and dissolved. Methanol is added to make 100 ml. Then 1 ml of this solution is diluted to 100 ml with 0.085% phosphoric acid Standard solution.
시험용액 및 표준용액에 대해서 0.085% 인산을 대조액으로 하여 파장 351nm 부근에서 흡광도 A1 및 A2를 측정하여 다음 계산식에 따라 효소처리 이소케르세틴의 함량(루틴환산양)을 구하고, 루틴환산양을 효소처리 이소케르세틴 함량으로 하였다.Absorbance A1 and A2 were measured at a wavelength of 351 nm using 0.085% phosphoric acid as a reference solution, and the content of enzyme-treated isoquercetin (in terms of rutin conversion) was determined according to the following equation, Quercetin content.
A : 효소처리루틴의 함량(루틴 환산양)(%)A: Contents of enzyme treatment routines (amount converted to rutin) (%)
A1 : 시험용액의 흡광도A1: absorbance of test solution
A2 : 표준용액의 흡광도A2: Absorbance of standard solution
S : 검체의 채취량(mg)S: Amount of sample (mg)
R : 루틴표준품의 채취량(mg)R: Weight of routine reference (mg)
상기 방법으로 분석한 결과 α-글리코실이소케르세틴의 함량이 약 70%인 것으로 확인되었다.Analysis by the above method revealed that the content of? -Glycosyl isoquercetin was about 70%.
시험예 4: α-글리코실이소케르세틴의 배당체 조성물 비율 분석Test Example 4: Analysis of glycoside composition ratio of? -Glycosyl isoquercetin
α-글리코실이소케르세틴 0.1g을 20% 에탄올로 녹인 후 100 mL가 되도록 하고, 위 용액을 취해 0.45μm membrane filter로 여과하여 시험용액으로 사용하였다.0.1 g of α-glycosyl isoquercetin was dissolved in 20% ethanol, and the solution was taken up to 100 mL. The solution was filtered through a 0.45 μm membrane filter and used as a test solution.
<HPLC 분석조건><HPLC analysis conditions>
1)칼람: C18 column (4.6 m × 250 mm, 5 μm) 1) Column: C18 column (4.6 m x 250 mm, 5 m)
2)이동상: 아세토니트릴(Acetonirtile):물=18:822) mobile phase: Acetonitrile: water = 18: 82
3)검출기 및 파장: UV at 254 nm3) Detector and wavelength: UV at 254 nm
4)유속: 0.8 mL/min4) Flow rate: 0.8 mL / min
5)주입량: 10㎕5) Injection amount: 10 μl
6)칼람온도: 상온6) Column temperature: room temperature
상기 방법으로 분석한 결과 α-글리코실이소케르세틴의 배당체 조성물 비율은 아래의 HPLC 크로마토그램 피크면적 비율(Area %)로 확인되었다(표 4, 도 1).As a result of the above analysis, the ratio of glycoside composition of? -Glycosyl isoquercetin was confirmed by the following HPLC chromatogram peak area ratio (Area%) (Table 4, Fig. 1).
Claims (9)
(B)생성된 람노오스를 반응계에서 제거하면서 효소 반응시키는 단계; 및
(C)효소를 실활시킨 후 이소케르세틴을 수득하는 단계를 포함하는 이소케르세틴의 제조방법.(A) treating the rutin with an enzyme having a long degradative activity and reacting;
(B) reacting the produced rhamnose with an enzyme while removing it from the reaction system; And
(C) inactivating the enzyme to obtain isoquercetin.
(A) a1)순도 95~98%의 루틴을 물에 분산시키고 pH 조정제를 사용하여 Ph3.5~8로 조정하는 단계; a2)나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계;
(B) b1)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리 후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b2)침전물을 물에 분산시키고 pH 조정제를 사용하여 pH3.5~8로 조정하고, 나린긴 분해활성을 갖는 효소를 첨가하여 30~80℃에서 교반하면서 반응시키는 단계; b3)20~24시간 유지 후, 20~25℃로 냉각하여 원심 분리후 상등액을 버리고, 침전물에 다시 물을 가하여 원심 분리한 후 상등액을 버리는 단계; b4)침전물을 다시 물에 분산시키고 효소 추가 투여 없이 30~80℃에서 교반하면서 20~24시간 반응시키는 단계; 및
(C)반응계에 남아 있는 효소를 실활시킨 후 침전물을 물로 세척, 건조하여 이소케르세틴을 회수하는 단계를 포함하는 이소케르세틴의 제조방법.The method according to claim 1,
(A) a1) dispersing a routine with a purity of 95 to 98% in water and adjusting the pH to 3.5 to 8 using a pH adjuster; a2) adding an enzyme having a long-lasting cleavage activity and reacting at 30 to 80 DEG C with stirring;
(B) b1) After 20 to 24 hours of keeping, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b2) dispersing the precipitate in water, adjusting the pH to 3.5 to 8 using a pH adjuster, adding an enzyme having a naringly digesting activity and reacting at 30 to 80 캜 with stirring; b3) After maintaining the temperature for 20 to 24 hours, the mixture is cooled to 20 to 25 DEG C, centrifuged, and the supernatant is discarded. Water is added to the precipitate again and centrifuged to discard the supernatant. b4) dispersing the precipitate in water again and reacting at 30 to 80 DEG C for 20 to 24 hours with no additional enzyme added; And
(C) deactivating the enzyme remaining in the reaction system, washing the precipitate with water, and drying the recovered isoquercetin to recover isoquercetin.
(n은 1~12의 정수)A process for producing? -Glycosyl isoquercetin represented by the following formula, which comprises the step of subjecting isoquercetin prepared by the production method of any one of claims 1 to 5 to a glycosyltransferase treatment in the presence of a sugar donor.
(n is an integer of 1 to 12)
(A) 제1항 내지 제5항 중 어느 한 항의 제조방법에 의하여 제조된 이소케르세틴에 물을 가하고 pH 조정제로 pH 5~8.5로 조정 후 30~80℃로 1~2 시간 유지시키는 단계;
(B)당공여체를 첨가하여 분산시키고, 당전이효소를 첨가하여 pH 5~8.5, 30~80℃조건에서 20~24시간 반응시키는 단계; 및
(C)효소를 실활시킨 후, 여과, 농축, 건조시켜 α-글리코실이소케르세틴을 회수하는 단계를 포함하는 α-글리코실이소케르세틴의 제조방법.The method according to claim 6,
(A) adding water to the isoquercetin prepared by the method of any one of claims 1 to 5, adjusting the pH to 5 to 8.5 with a pH adjusting agent, and maintaining the temperature at 30 to 80 ° C for 1 to 2 hours;
(B) a donor is added and dispersed, and a reaction is carried out at pH 5 to 8.5 and 30 to 80 ° C for 20 to 24 hours by adding a sugar transferase; And
(C) inactivating the enzyme, followed by filtration, concentration, and drying to recover the? -Glycosyl isoquercetin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180000228A KR102528136B1 (en) | 2018-01-02 | 2018-01-02 | Method for preparation of isoquercetin and α-glycosylisoquercetin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180000228A KR102528136B1 (en) | 2018-01-02 | 2018-01-02 | Method for preparation of isoquercetin and α-glycosylisoquercetin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20190082524A true KR20190082524A (en) | 2019-07-10 |
| KR102528136B1 KR102528136B1 (en) | 2023-05-02 |
Family
ID=67255131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020180000228A Active KR102528136B1 (en) | 2018-01-02 | 2018-01-02 | Method for preparation of isoquercetin and α-glycosylisoquercetin |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102528136B1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210073070A (en) * | 2019-12-10 | 2021-06-18 | 경희대학교 산학협력단 | Preparation method of flavonol-3-isoglycosides |
| CN114686549A (en) * | 2022-04-29 | 2022-07-01 | 陕西嘉禾生物科技股份有限公司 | Method for preparing enzyme modified isoquercitrin by using rutin |
| CN115011654A (en) * | 2022-03-31 | 2022-09-06 | 成都欧康医药股份有限公司 | A kind of method for preparing isoquercetin by enzymatic hydrolysis of Sophora japonica |
| CN115997928A (en) * | 2022-12-06 | 2023-04-25 | 广东金骏康生物技术有限公司 | Application of a kind of soluble sophora rice flour in weight loss products |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010080330A (en) * | 1998-10-30 | 2001-08-22 | 플레믹 크리스티안 | Method for enzymatic splitting of rutinosides |
| KR20030013371A (en) * | 2000-02-11 | 2003-02-14 | 메르크 파텐트 게엠베하 | Method for producing monoglycosidated flavonoids |
| KR20070094638A (en) * | 2004-12-28 | 2007-09-20 | 산토리 가부시키가이샤 | Quercetin glycoside composition and preparation method thereof |
-
2018
- 2018-01-02 KR KR1020180000228A patent/KR102528136B1/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010080330A (en) * | 1998-10-30 | 2001-08-22 | 플레믹 크리스티안 | Method for enzymatic splitting of rutinosides |
| JP2002528133A (en) * | 1998-10-30 | 2002-09-03 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Method for enzymatic degradation of rutinoside |
| KR20030013371A (en) * | 2000-02-11 | 2003-02-14 | 메르크 파텐트 게엠베하 | Method for producing monoglycosidated flavonoids |
| KR20070094638A (en) * | 2004-12-28 | 2007-09-20 | 산토리 가부시키가이샤 | Quercetin glycoside composition and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210073070A (en) * | 2019-12-10 | 2021-06-18 | 경희대학교 산학협력단 | Preparation method of flavonol-3-isoglycosides |
| CN115011654A (en) * | 2022-03-31 | 2022-09-06 | 成都欧康医药股份有限公司 | A kind of method for preparing isoquercetin by enzymatic hydrolysis of Sophora japonica |
| CN114686549A (en) * | 2022-04-29 | 2022-07-01 | 陕西嘉禾生物科技股份有限公司 | Method for preparing enzyme modified isoquercitrin by using rutin |
| CN115997928A (en) * | 2022-12-06 | 2023-04-25 | 广东金骏康生物技术有限公司 | Application of a kind of soluble sophora rice flour in weight loss products |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102528136B1 (en) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100923665B1 (en) | Method of extracting and method of purifying an effective substance | |
| KR102528136B1 (en) | Method for preparation of isoquercetin and α-glycosylisoquercetin | |
| US10676496B2 (en) | Method for producing flavonoid inclusion compound | |
| JP4498277B2 (en) | Process for the preparation of α-glycosylisoquercitrin and its intermediates and by-products | |
| EP1838862B1 (en) | Manufacturing method of kaempferol | |
| US6420142B1 (en) | Method for enzymatic splitting of rutinosides | |
| KR100379642B1 (en) | A process of manufacturing highly purified isoflavone aglycones by fermentation | |
| JP4023539B2 (en) | Extraction method and purification method of active substance | |
| KR101561505B1 (en) | Method for producing isoflavones aglycone from soybean embryo | |
| JPH10323196A (en) | Production of alpha-monoglucosylhesperidin high-content substance | |
| JP5985229B2 (en) | Process for producing sugar adducts of poorly water-soluble polyphenols | |
| KR102390654B1 (en) | Preparation method of flavonol-3-isoglycosides | |
| JP2011051933A (en) | alpha-GLYCOSYL ANTHOCYANIN | |
| JPS6152671B2 (en) | ||
| JP2011041531A (en) | Method for producing flavonoid compound | |
| CN120330280A (en) | A method for preparing a glucosyl-modified quercetin derivative | |
| KR20240113284A (en) | Method for production of fisetin inclusion complex using cyclodextrin glucanotransferase | |
| KR20220074338A (en) | A preparation method of rutin glycoside, and cosmetic and food composition for antiaging comprising the same | |
| JP2021011455A (en) | PHLORETIN-4-α-GLUCOSIDE CRYSTAL | |
| CN113817786A (en) | Method for preparing rhamnosyl fructose by enzyme method | |
| KR20080049413A (en) | Method of Making Astragaline | |
| KR20050061007A (en) | Enzymatic transglycosylation of l-ascorbic acid in a heterogeneous enzyme reaction system using insoluble starch as the glycosyl donor | |
| CZ307927B6 (en) | Heterogeneous method of manufacturing rutinos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20180102 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20201208 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20180102 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221216 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230426 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230427 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20230427 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |